Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Gamat

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Endocrine-Related Cancer|August 18, 2017
Androgen deprivation and immunotherapy for the treatment of prostate cancerMelissa Gamat, Douglas G McNeel
Journal for Immunotherapy of Cancer|May 21, 2024
Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacyAnusha Muralidhar, Melissa Gamat-Huber, Sita Vakkalanka, et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|September 26, 2015
FOXA1 and SOX9 Expression in the Developing Urogenital Sinus of the Tammar Wallaby (Macropus eugenii)Melissa Gamat, Keng Yih Chew, Geoffrey Shaw, et al.
Plos One|October 2, 2015
Ornithine Decarboxylase Activity Is Required for Prostatic Budding in the Developing Mouse ProstateMelissa Gamat, Rita L Malinowski, Linnea J Parkhurst, et al.
Cancer Immunology Research|October 21, 2017
Prostate Cancer Cells Express More Androgen Receptor (AR) Following Androgen Deprivation, Improving Recognition by AR-Specific T CellsBrian M Olson, Melissa Gamat, Joseph Seliski, et al.
Cancers|October 3, 2020
Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)Melissa Gamat-Huber, Donghwan Jeon, Laura E Johnson, et al.
Journal for Immunotherapy of Cancer|March 17, 2022
Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancerSafae Terrisse, Anne-Gaelle Goubet, Kousuke Ueda, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Endocrine-Related Cancer|August 18, 2017
Androgen deprivation and immunotherapy for the treatment of prostate cancerMelissa Gamat, Douglas G McNeel
Journal for Immunotherapy of Cancer|May 21, 2024
Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacyAnusha Muralidhar, Melissa Gamat-Huber, Sita Vakkalanka, et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|September 26, 2015
FOXA1 and SOX9 Expression in the Developing Urogenital Sinus of the Tammar Wallaby (Macropus eugenii)Melissa Gamat, Keng Yih Chew, Geoffrey Shaw, et al.
Plos One|October 2, 2015
Ornithine Decarboxylase Activity Is Required for Prostatic Budding in the Developing Mouse ProstateMelissa Gamat, Rita L Malinowski, Linnea J Parkhurst, et al.
Cancer Immunology Research|October 21, 2017
Prostate Cancer Cells Express More Androgen Receptor (AR) Following Androgen Deprivation, Improving Recognition by AR-Specific T CellsBrian M Olson, Melissa Gamat, Joseph Seliski, et al.
Cancers|October 3, 2020
Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)Melissa Gamat-Huber, Donghwan Jeon, Laura E Johnson, et al.
Journal for Immunotherapy of Cancer|March 17, 2022
Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancerSafae Terrisse, Anne-Gaelle Goubet, Kousuke Ueda, et al.
Pageof 1